T1	Participants 99 122	breast cancer patients.
T2	Participants 733 791	cancer patients receiving chemotherapy and/or radiotherapy
T3	Participants 890 981	fifty-eight breast cancer patients who received chemotherapy or radiotherapy were enrolled.
